top of page

CORONAVIRUS DISEASE 2019 (COVID-19) TREATMENT GUIDELINES
MARCH, 2021

The guidance is based on proper case management aspects intended for clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not meant to replace clinical judgment or specialist consultation but rather to strengthen frontline clinical management and the public health response.

NOTE. THIS GUIDELINE IS THE PROPERTY OF MINISTRY OF HEALTH, COMMUNITY DEVELOPMENT, GENDER, ELDERLY AND CHILDREN.

2.	SCREENING AND TRIAGING

2. SCREENING AND TRIAGING

2.1. Symptoms associated with COVID-19

Triaging according to severity of COVID 19 Patient

Mild covid-19 disease

Moderate covid-19 disease(pneumonia)

Severe covid-19 disease (severe pneumonia)

Critical disease-Acute respiratory distress syndrome (ARDS)

Critical disease (sepsis)

Critical disease (septic shock)

Note

1.  INTRODUCTION

1. INTRODUCTION

1.a. Disease pathophysiology (time course of the disease)

Phase I:

Phase II:

Phase III

Phase IV

3. INITIAL PATIENT APPROACH

3. INITIAL PATIENT APPROACH

ABCDE approach

A – Airway

B – Breathing

C – Circulation

D – Disability

E – Exposure

Note

4.	MANAGEMENT BASED ON DISEASE SEVERITY

4. MANAGEMENT BASED ON DISEASE SEVERITY

a. Mild covid-19 disease (home care)

b. Moderate covid-19 disease (pneumonia)

c. Severe covid-19 disease (severe pneumonia)

d. Critical disease

NOTE

5.	RESPIRATORY MANAGEMENT FOR COVID-19 PATIENT

5. RESPIRATORY MANAGEMENT FOR COVID-19 PATIENT

1. Oxygenation and Ventilation

a. Low Flow nasal canula

b. Simple face mask

c. Non – rebreather Mask

d. Cpap face mask

e. Bag-valve mask (ambu bag)

f. Bag-valve mask (ambu bag)

g. High Flow Nasal Canula

2. Note

3. Recognize severe hypoxemic respiratory failure

bottom of page